Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1950 1
1951 1
1952 2
1953 2
1954 1
1956 1
1960 1
1964 1
1965 1
1967 1
1968 2
1969 1
1982 1
1983 2
1988 1
2000 1
2003 1
2004 3
2005 5
2006 4
2007 2
2008 4
2009 3
2010 2
2011 2
2012 3
2013 6
2014 4
2015 5
2016 4
2017 7
2018 9
2019 16
2020 11
2021 7
2022 11
2023 7
2024 6
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.
Editorial.
Maxeiner S, Tschernig T, Brenner E. Maxeiner S, et al. Ann Anat. 2022 Aug;243:151947. doi: 10.1016/j.aanat.2022.151947. Epub 2022 Apr 22. Ann Anat. 2022. PMID: 35470052 No abstract available.
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Hernandez AF, et al. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2. Lancet. 2018. PMID: 30291013 Free article. Clinical Trial.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia.
Abdel Wadood N, Hollenhorst MI, Elhawy MI, Zhao N, Englisch C, Evers SB, Sabachvili M, Maxeiner S, Wyatt A, Herr C, Burkhart AK, Krause E, Yildiz D, Beckmann A, Kusumakshi S, Riethmacher D, Bischoff M, Iden S, Becker SL, Canning BJ, Flockerzi V, Gudermann T, Chubanov V, Bals R, Meier C, Boehm U, Krasteva-Christ G. Abdel Wadood N, et al. Among authors: maxeiner s. Nat Commun. 2025 Jan 10;16(1):584. doi: 10.1038/s41467-025-55936-5. Nat Commun. 2025. PMID: 39794305 Free PMC article.
Diabetes and Road Traffic.
Ebert O, Bohn B, Bertram B, Buchberger B, Finck H, Hoß J, Hübner P, Krabbe L, Kulzer B, Küstner E, Lachenmayr B, Lemmen KD, Petry F, Rinnert K, Salomon M, Schütt W, Holl RW, Maxeiner S, Wagener W. Ebert O, et al. Among authors: maxeiner s. Exp Clin Endocrinol Diabetes. 2024 Sep;132(9):481-496. doi: 10.1055/a-2166-6928. Epub 2024 Feb 23. Exp Clin Endocrinol Diabetes. 2024. PMID: 38395055 Free article. No abstract available.
THE ACUTE ABDOMEN.
MAXEINER SR Jr. MAXEINER SR Jr. Minn Med. 1964 Jul;47:782-6. Minn Med. 1964. PMID: 14243314 No abstract available.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
137 results